These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32297434)

  • 1. Improving Cancer Immunotherapy Outcomes Using Biomaterials.
    Yan S; Luo Z; Li Z; Wang Y; Tao J; Gong C; Liu X
    Angew Chem Int Ed Engl; 2020 Sep; 59(40):17332-17343. PubMed ID: 32297434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomaterial-assisted photoimmunotherapy for cancer.
    Chen M; Chen Q
    Biomater Sci; 2020 Nov; 8(21):5846-5858. PubMed ID: 33016276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomaterials promote
    Qin YT; Li YP; He XW; Wang X; Li WY; Zhang YK
    Front Immunol; 2023; 14():1165576. PubMed ID: 37153571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.
    Lei K; Tang L
    Biomater Sci; 2019 Feb; 7(3):733-749. PubMed ID: 30637428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Vaccine and Immunotherapy Design Using Biomaterials.
    Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
    Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short Review on Advances in Hydrogel-Based Drug Delivery Strategies for Cancer Immunotherapy.
    Seo HS; Wang CJ; Park W; Park CG
    Tissue Eng Regen Med; 2022 Apr; 19(2):263-280. PubMed ID: 34596839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boosting Checkpoint Immunotherapy with Biomaterials.
    Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
    ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-based hydrogels with local drug release for cancer immunotherapy.
    Xie Z; Shen J; Sun H; Li J; Wang X
    Biomed Pharmacother; 2021 May; 137():111333. PubMed ID: 33571834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells.
    Desai N; Hasan U; K J; Mani R; Chauhan M; Basu SM; Giri J
    Acta Biomater; 2023 Apr; 161():1-36. PubMed ID: 36907233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses.
    Chen Q; Chen M; Liu Z
    Chem Soc Rev; 2019 Nov; 48(22):5506-5526. PubMed ID: 31589233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy.
    Chen W; Li C; Jiang X
    Small Methods; 2023 May; 7(5):e2201404. PubMed ID: 36811240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.
    Wang C; Ye Y; Hu Q; Bellotti A; Gu Z
    Adv Mater; 2017 Aug; 29(29):. PubMed ID: 28556553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the clinical impact of biomaterials in cancer immunotherapy.
    Gammon JM; Dold NM; Jewell CM
    Oncotarget; 2016 Mar; 7(13):15421-43. PubMed ID: 26871948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy.
    Ruan S; Huang Y; He M; Gao H
    Adv Sci (Weinh); 2022 May; 9(16):e2200027. PubMed ID: 35343112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supramolecular biomaterials for enhanced cancer immunotherapy.
    Zhang H; Zhu J; Fang T; Li M; Chen G; Chen Q
    J Mater Chem B; 2022 Sep; 10(37):7183-7193. PubMed ID: 35348177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Sep; 138(38):12502-10. PubMed ID: 27575718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Stimuli-Responsive Platforms for Cancer Immunotherapy.
    Li L; Yang Z; Chen X
    Acc Chem Res; 2020 Oct; 53(10):2044-2054. PubMed ID: 32877161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy.
    Lee D; Huntoon K; Wang Y; Jiang W; Kim BYS
    Adv Mater; 2021 Jul; 33(27):e2007576. PubMed ID: 34050699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.